Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Approved by the FDA in 2014, this drug is specifically designed to help adults with obesity or those who are overweight and have weight-related health issues
When injecting the medication, rotate sites or avoid injecting it in the same spot twice in a row
Above 8 degrees, degradation accelerates
February 2025: FDA resolves the semaglutide shortage, citing Novo Nordisk capacity expansion
Ellen and Scott Antoine lead a team that listens like it matters (because it does)
US$ 29.36
US$ 24.21
US$ 22.40
/assets/production/practices/438b59b4e27c5dc64b6d75ab18cf4e16804f233b/images/2831064.png)
US$ 21.30
